FDA Approves New Bladder Cancer Drug FDA Approves New Bladder Cancer Drug

The first-in-class agent is approved alongside bacillus Calmette-Gu érin to treat certain non–muscle-invasive bladder cancers that do not respond to bacillus Calmette-Guérin alone.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news